AC
NVRO

Armistice Capital’s NEVRO CORP. NVRO Stock Holding History

Armistice Capital’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,736,000
Closed -$13.9M – 289
2024
Q4 		$13.9M Buy
3,736,000
+8,000
+0.2% +$36.9K 0.19% 83
2024
Q3 		$20.8M Buy
3,728,000
+56,000
+2% +$392K 0.33% 58
2024
Q2 		$30.9M Buy
3,672,000
+48,000
+1% +$512K 0.39% 48
2024
Q1 		$52.3M Buy
3,624,000
+448,000
+14% +$7.41M 0.69% 18
2023
Q4 		$68.3M Sell
3,176,000
-280,000
-8% -$5M 0.93% 16
2023
Q3 		$66.4M Buy
3,456,000
+1,100,000
+47% +$23.5M 1.02% 12
2023
Q2 		$59.9M Buy
+2,356,000
New +$68M 0.87% 24

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Armistice Capital's NVRO Position: Q1 2025 in Review

Armistice Capital sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 3,736,000 shares — an estimated $13.9M sold.

Armistice Capital first reported a position in NVRO in Q2 2023 and held it in 7 quarters. The position peaked at $68.3M in Q4 2023. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Armistice Capital reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Armistice Capital sold 3,736,000 NEVRO CORP. shares in Q1 2025, an estimated $13.9M.
  • Armistice Capital first reported a position in NEVRO CORP. in Q2 2023 and held it in 7 quarters.
  • Armistice Capital's NEVRO CORP. position peaked at $68.3M in Q4 2023.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.